Post-approval studies (Phase 4)Study completedNCT01770145
What this trial is testing
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
Who this might be right for
Parkinson's DiseaseMotor SymptomsAkinesia+2 more
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 127